HCA Healthcare Appoints Frank Morgan Vice President of Investor Relations

HCA Healthcare, Inc. (NYSE: HCA), one of the nation’s leading healthcare providers, today announced Frank Morgan will become vice president of investor relations, effective January 1, 2022.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211222005107/en/

HCA Healthcare Appoints Frank Morgan as VP of Investor Relations (Photo: Business Wire)

HCA Healthcare Appoints Frank Morgan as VP of Investor Relations (Photo: Business Wire)

Morgan, who currently is managing director of healthcare services research for RBC Capital Markets, has covered the healthcare industry as a financial analyst for more than 30 years. He will succeed Mark Kimbrough who is retiring in March after a nearly 40-year career with HCA Healthcare.

“Frank is well known and well respected by the investment community, having covered the facility-based healthcare services sector for many years,” said HCA Healthcare executive vice president and chief financial officer Bill Rutherford. “His familiarity with the healthcare industry and our company will serve him well, and we look forward to welcoming him to HCA Healthcare.”

Morgan joined RBC Capital Markets in 2008 after serving as managing director and senior analyst at Jefferies and Company from 2000 to 2008. Before that he was a partner and senior analyst at J.C. Bradford from 1995 to 2000. A chartered financial analyst (CFA), Morgan has earned national recognition for his research and coverage of the medical care sector. He has a bachelor’s degree in microbiology and an MBA from the University of Alabama.

Kimbrough began his HCA Healthcare career in the company’s internal audit department in 1982. He held positions in operations, home care, senior living services and development before joining the company’s investor relations department in 1986. Kimbrough was appointed assistant vice president, investor relations in 1997 and vice president, investor relations in 2000. From 2006 to 2011, when HCA Healthcare was privately held, he served as vice president of real estate. Kimbrough returned to investor relations upon HCA Healthcare’s initial public offering in 2011, and he has been recognized consistently as a top IR executive by Institutional Investor.

“Mark is highly respected among the investor community. He has built strong and enduring relationships on behalf of HCA Healthcare during the many years he has served as our company’s primary contact for investors and analysts,” said Rutherford. “We appreciate his nearly four decades of service to HCA Healthcare, and we wish him well in retirement.”

About HCA Healthcare

Nashville-based HCA Healthcare is one of the nation’s leading providers of healthcare services comprising 183 hospitals and approximately 2,000 ambulatory sites of care, including surgery centers, freestanding ERs, urgent care centers, and physician clinics, in 20 states and the United Kingdom. With its founding in 1968, HCA Healthcare created a new model for hospital care in the United States, using combined resources to strengthen hospitals, deliver patient-focused care and improve the practice of medicine. HCA Healthcare has conducted a number of clinical studies, including one that demonstrated that full-term delivery is healthier than early elective delivery of babies and another that identified a clinical protocol that can reduce bloodstream infections in ICU patients by 44 percent. HCA Healthcare is a learning health system that uses its more than 32 million annual patient encounters to advance science, improve patient care and save lives. Please click here to connect with HCA Healthcare on social media.

All references to “Company,” “HCA” and “HCA Healthcare” as used throughout this document refer to HCA Healthcare, Inc. and its affiliates.

Contacts

INVESTOR CONTACT:

Mark Kimbrough

615-344-2688

MEDIA CONTACT:

Harlow Sumerford

615-344-1851

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.